Results 181 to 190 of about 15,755,820 (216)
Some of the next articles are maybe not open access.

ST2 and mortality in non–ST-segment elevation acute coronary syndrome

American Heart Journal, 2010
ST2 is a member of the interleukin-1 receptor family that is up-regulated in conditions associated with increased myocardial strain. ST2 has been shown to be independently predictive of adverse outcome in heart failure and ST-segment elevation myocardial infarction, but its prognostic value in non-ST-elevation acute coronary syndrome (NSTE-ACS) has not
Eggers, KM   +6 more
openaire   +3 more sources

Non-ST Segment Elevation Acute Coronary Syndromes: A Comprehensive Review

Southern Medical Journal, 2006
As the non-ST segment elevation acute coronary syndromes (NSTEACS) include unstable angina pectoris (UAP) and the non-ST segment elevation myocardial infarction (NSTEMI), acute diagnosis and risk stratification can often prove challenging. This review will cover guidelines and strategies for risk assessment, contemporary approaches to acute patient ...
Abelardo, Martinez-Rumayor   +1 more
openaire   +2 more sources

Anticoagulation in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome

Journal of Pharmacy Practice, 2010
There are currently over 1 million patients admitted to hospitals in the United States with the diagnosis of non-ST-segment elevation acute coronary syndrome (NSTE ACS). Due to the significant morbidity and mortality associated with NSTE ACS, appropriate use of the numerous medications employed is critical in ensuring optimal outcomes.
Paul P, Dobesh, Toby C, Trujillo
openaire   +2 more sources

Speckle Tracking Echocardiography in Non–ST-Segment Elevation Acute Coronary Syndromes

Current Problems in Cardiology, 2021
Non-ST-segment elevation acute coronary syndromes (NSTE-ACSs) are a group of clinical conditions characterized by acute myocardial ischemia. Conventional echocardiography is generally used to evaluate cardiac function using wall motion analysis and left ventricular ejection fraction but may be insufficient to explore all the complex features of NSTE ...
D, Mele   +7 more
openaire   +2 more sources

Non–ST-Segment Elevation Acute Coronary Syndrome

AACN Advanced Critical Care, 2011
Of the nearly 1.4 million hospitalizations for acute coronary syndromes in 2006, approximately two-thirds were for unstable angina (UA) or non–ST-segment elevation myocardial infarction (NSTEMI). Given the high risk for in-hospital ischemic events and late mortality in patients with UA/NSTEMI, it is critical to accurately and rapidly diagnose these ...
openaire   +1 more source

Antiplatelet Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes

JAMA, 2004
Acute coronary syndromes are a frequent cause of hospital admission for patients with coronary artery disease. The pathophysiology of acute coronary syndromes often involves plaque rupture or fissure with platelet aggregation. Recognition of the importance of platelet aggregation resulted in several large randomized trials testing 3 types of platelet ...
openaire   +2 more sources

Pathogenesis and Early Management of Non–ST-segment Elevation Acute Coronary Syndromes

Cardiology Clinics, 2006
NSTE ACS is a clinically significant problem. Endothelial dysfunction triggered by traditional cardiovascular risk factors (and perhaps by other as yet unidentified risks) in the susceptible host leads to the formation and development of atherosclerotic plaque.
Tomas H, Ayala, Steven P, Schulman
openaire   +2 more sources

Managing patients with non-ST-segment elevation acute coronary syndrome

Nursing Standard, 2006
Acute coronary syndromes (ACSs) can be described as ST-segment elevation or non-ST-segment elevation, including unstable angina. Traditionally, ST-segment elevation ACS has been considered to be more serious, but non-ST-segment elevation ACS has higher mortality rates in the longer term.
openaire   +2 more sources

Transfusion practice and outcomes in non–ST-segment elevation acute coronary syndromes

American Heart Journal, 2008
To describe the association between transfusion and outcomes as a function of nadir hematocrit (HCT) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS).The adverse outcomes associated with transfusion in NSTE ACS is uncertain and may vary by nadir HCT of the transfused.Using data from 44242 patients with NSTE ACS in 400 US ...
Karen P, Alexander   +10 more
openaire   +2 more sources

Cardiogenic Shock Complicating Non-ST-Segment Elevation Acute Coronary Syndrome

2002
Classically, cardiogenic shock has been considered a sequela of ST-segment elevation myocardial infarction, most commonly caused by left ventricular dysfunction resulting from ongoing ischemia and cell necrosis. In keeping with this scenario, most of the current literature on cardiogenic shock confines itself to ST-segment elevation.
David R. Holmes, David Hasdai
openaire   +1 more source

Home - About - Disclaimer - Privacy